002099 海翔药业
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额146,610240,537116,092102,361533,870
投资活动产生之现金流量净额(130,487)(128,215)(620,316)(509,007)(70,581)
筹资活动产生之现金流量净额19,52599,070(121,882)80,786(11,189)
汇率变动对现金及现金等价物的影响10,4441,10475,133(25,534)(38,476)
现金及现金等价物净增加/(减少)46,092212,496(550,973)(351,394)413,624
期初现金及现金等价物余额1,249,5311,037,0351,588,0081,939,4021,525,778
期末现金及现金等价物余额1,295,6231,249,5311,037,0351,588,0081,939,402